Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 14/20 | 0.65 |
| ▸ | F2 | P00734 | 12/20 | 0.65 |
| ▸ | PLG | P00747 | 4/20 | 0.42 |
| ▸ | PLAU | P00749 | 4/20 | 0.42 |
| ▸ | PLAT | P00750 | 4/20 | 0.42 |
| ▸ | NEK2 | P51955 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6576178 | 0.94 | F10 (0.74) | F10F2PLGPLAUPLAT | |
| SCHEMBL6576934 | 0.86 | F10 (0.70) | F10F2PLGPLAUPLAT | |
| SCHEMBL6579641 | 0.86 | F10 (0.74) | F10F2 | |
| SCHEMBL6581356 | 0.83 | F10 (0.74) | F10F2 | |
| SCHEMBL6576738 | 0.83 | F10 (0.74) | F10F2 | |
| SCHEMBL6578632 | 0.82 | F10 (0.78) | F10F2PLGPLAUPLAT | |
| SCHEMBL6578558 | 0.82 | F10 (0.75) | F10F2PLGPLAUPLAT | |
| SCHEMBL6579903 | 0.82 | F10 (0.72) | F10F2PLGPLAUPLAT | |
| SCHEMBL6581540 | 0.81 | F10 (0.72) | F10F2PLGPLAUPLAT | |
| SCHEMBL7550943 | 0.81 | F10 (0.63) | F10F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020032223-A1 | Benzamidine derivatives and their use as anti-coagulants | BERLEX LABORATORIES, INC. | 2002-03-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020032223-A1 | Benzamidine derivatives and their use as anti-coagulants | SERPINC1, HABP2, SERPINE1 | F10 44/4885F2 4/4885PLG 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.